Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
The Library of Congress has announced Arthur Sze as the 25th U.S. poet laureate. Sze has...
Democratic Rep. Jerry Nadler of New York says he will not run for reelection next year,...
In late February of 2024, Jordanian cargo planes flew over northern Gaza, dropping large pallets of...
